HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation China202180061706.7Filed on 2023-03-08
HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Australia2021310213Filed on 2023-02-03
HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation Canada3185241Filed on 2023-01-06
HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION Read more about HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION Japan2023-502572Filed on 2023-01-12
METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM TUMOR Read more about METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM TUMOR US Application 18/093,902Filed on 2023-01-06
Combination Immunotherapy Compositions And Methods Read more about Combination Immunotherapy Compositions And Methods US Application 17/130,551Filed on 2020-12-22
Combination Immunotherapy Compositions And Methods Read more about Combination Immunotherapy Compositions And Methods US Application 16/951,739Filed on 2020-11-18
Viral Methods Of T Cell Therapy Read more about Viral Methods Of T Cell Therapy Japan2022-185536Filed on 2022-11-21
COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF Read more about COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF Patent Cooperation TreatyPCT/US2022/051249Filed on 2022-11-29
USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS Read more about USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS US Application 17/775,262Filed on 2022-05-06